Becher
Benjamin John Becher, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20100091039 | COLOR CORRECTION OF ELECTRONIC DISPLAYS - A method for adjusting the characteristics of a display. The method for adjusting the characteristics of the display may include constructing color models as a function of a parameter such as temperature. Furthermore, the color model may be used to determine adjustment values to be applied to a display. The adjustment values may be organized in a table as a function of temperature and color values. The adjustment values may be determined from measurements. | 04-15-2010 |
Burkhard Becher, Maur CH
Patent application number | Description | Published |
---|---|---|
20080292590 | Soluble Receptors and Methods for Treating Autoimmune or Demyelinating Diseases - The present invention relates to novel therapeutic protein useful in the treatment of diseases, in particular in human subjects. The results of the inventor strongly support the use of soluble IL-18Rα in the treatment of diseases such as autoimmune or demyelinating disease, in particular Multiple Sclerosis (MS). Accordingly, the invention provides soluble IL-18Rα for use in the treatment of autoimmune or demyelinating disease, in particular MS. The invention also provides methods of treating, preventing or ameliorating the symptoms of autoimmune or demyelinating disease, in particular MS, in a subject, preferably a human subject, by administering a therapeutically effective amount of said soluble IL-18Rα to the subject. | 11-27-2008 |
20080317710 | Methods For Treating Autoimmune or Demyelinating Diseases - The present invention relates to novel therapeutic or prophylactic treatment in human subjects. The present invention results in part from the discovery that antagonists of IL-18Rα are effective in vivo for treating diseases. Accordingly, the invention provides a method of treating, preventing or ameliorating the symptoms of an autoimmune or demyelinating disease (such as multiple sclerosis) in a subject, preferably a human subject, said method comprising administering to the subject a therapeutically effective amount of an antagonist of IL-18Rα. The invention also pertains to the use of an antagonist of IL-18Rα in the manufacture of a medicament for the treatment of an autoimmune or demyelinating diseases (such as multiple sclerosis). | 12-25-2008 |
20130302343 | MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE - The invention provides antibody against p40, IL-12 or IL-23 for the prevention or treatment of Alzheimer's disease. It further provides ligands to the pair of interleukin 12 or 23 and its specific receptor, specifically an antibody, an antibody fragment, an antibody-like-molecule, for the prevention or treatment of Alzheimer's disease. Similarly, siRNA, antisense or transcription factor modulators of gene expression of p19, p35, p40, IL-12R-β1, IL-12R-β2, and/or IL-23R for the prevention or treatment of Alzheimer's disease are provided. | 11-14-2013 |
20150017121 | COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY - The invention relates to a combination medicament for treatment of malignant neoplastic disease. The combination medicament comprises an IL-12 polypeptide having a biological activity of IL-12 or a nucleic acid expression vector comprising a sequence encoding such IL-12 polypeptide, and a non-agonist CTLA-4 ligand or non-agonist PD-1 ligand, particularly an anti-CTLA-4 or anti-PD-1 immunoglobulin G. | 01-15-2015 |
James A. Becher, Fort Wayne, IN US
Patent application number | Description | Published |
---|---|---|
20130184933 | Apparatus and Method for Selectively Restricting or Disabling Electronic Device Functionality - An apparatus that restricts or disables electronic device functionality based on vehicle status data received from the on-board computer (“OBD”) of a public service vehicle. In some embodiments, the vehicle status data is accessed from the OBD through an assembly line diagnostic link (“ALDL”) connector, which eliminates any need for modification of the vehicle during installation. If the software determines the vehicle status data is outside a preset range, which could be customized on a case-by-case basis, the on-board computer of the vehicle could be restricted or disabled until the vehicle status data returns to within the preset range. | 07-18-2013 |
Klemens Becher, Horsching AT
Patent application number | Description | Published |
---|---|---|
20120240813 | CHASSIS FRAME FOR RAIL VEHICLES - A chassis frame for rail vehicles includes two longitudinal beams and at least one transverse beam which is disposed between the longitudinal beams and hinged thereto. The longitudinal beams are designed in a bent shape and extend through a corresponding cutout of the transverse beam. | 09-27-2012 |
Mariela Paula Becher, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20100152244 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION - A self-emulsifying formulation of tipranavir for oral administration. | 06-17-2010 |
Paul F. Becher, Oak Ridge, TN US
Patent application number | Description | Published |
---|---|---|
20100267543 | USE OF ADDITIVES TO IMPROVE MICROSTRUCTURES AND FRACTURE RESISTANCE OF SILICON NITRIDE CERAMICS - A high-strength, fracture-resistant silicon nitride ceramic material that includes about 5 to about 75 wt-% of elongated reinforcing grains of beta-silicon nitride, about 20 to about 95 wt-% of fine grains of beta-silicon nitride, wherein the fine grains have a major axis of less than about 1 micron; and about 1 to about 15 wt-% of an amorphous intergranular phase comprising Si, N, O, a rare earth element and a secondary densification element. The elongated reinforcing grains have an aspect ratio of 2:1 or greater and a major axis measuring about 1 micron or greater. The elongated reinforcing grains are essentially isotropically oriented within the ceramic microstructure. The silicon nitride ceramic exhibits a room temperature flexure strength of 1,000 MPa or greater and a fracture toughness of 9 MPa-m | 10-21-2010 |
Thomas Alois Becher, Mclean, VA US
Patent application number | Description | Published |
---|---|---|
20130110388 | Terminal Aircraft Sequencing and Conflict Resolution | 05-02-2013 |
Yona Becher, Budd Lake, NJ US
Patent application number | Description | Published |
---|---|---|
20120211502 | Transportable and built on-site container apparatus with controlled floatation and with self-collecting means for water flooding emergency - Floating and towable multiple container apparatus, each container apparatus ( | 08-23-2012 |